Serum and cerebrospinal fluid cystatin C levels in vascular and Alzheimer's dementia

Acta Neurologica Scandinavica

Volumn 101, Issue 4, 2000, Pages 279-282

  Kalman J ^a   Marki Zay J ^a   Juhasz A ^a   Santha A ^a   Dux, L ^a   Janka, Z ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Cystatin C; Serum; Vascular dementia

Indexed keywords

AMYLOID BETA PROTEIN; CYSTATIN C; CYSTEINE PROTEINASE INHIBITOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIINFARCT DEMENTIA; NERVE REGENERATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; VASCULAR AMYLOIDOSIS;

EID: 0034057048     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2000.101004279.x     Document Type: Article

References (29)

1. 1. Assfalg-Machleidt I, Billing A, Frohlich D et al. The role of the kininogens as cysteine proteinase inhibitors in local and systemic inflammation. Agents Actions Suppl 1992;38: 312-21.
2. 2. Colle A, Tavera C, Prevot D et al. Cystatin C levels in sera of patients with human immunodeficiency virus infection. A new avidin-biotin ELISA assay for its measurement. J Immunoassay 1992;13:47-60.
3. 3. Yasuhara O, Hanai K, Ohkubo I, Sasaki M, McGeer PL, Kimura H. Expression of cystatin C in rat, monkey and human brains. Brain Res 1993;628:85-92.
4. 4. Aldred AR, Brack CM, Schreiber G. The cerebral expression of plasma protein genes in different species. Comp Biochem Physiol B Biochem Mol Biol 1995;111:1-15.
5. 5. Ohe Y, Ishikawa K, Itoh Z, Tatemoto K. Cultured leptomeningeal cells secrete cerebrospinal fluid proteins. J Neurochem 1996;67:964-71.
6. 6. Palm DE, Knuckey NW, Primiano MJ, Spangenberger AG, Johanson CE. Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia. Brain Res 1995;691:1-8.
7. 7. Ishimaru H, Ishikawa K, Ohe Y, Takahashi A, Maruyama Y. Cystatin C and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil neurons. Brain Res 1996; 709:155-62.
8. 8. Miyake T, Gahara Y, Nakayama M, Yamada H, Uwabe K, Kitamura T. Up-regulalion of cystatin C by microglia in the rat facial nucleus following axotomy. Brain Res Mol Brain Res 1996;37:273-82.
9. 9. Katakai K, Shinoda M, Kabeya K et al. Changes in distribution of cystatin C, apolipoprotein E and ferritin in rat hypothalamus after hypophysectomy. J Neuroendocrinol 1997;9:247-53.
10. 10. Wang ZZ, Jensson O, Thorsteinsson L, Vinters HV. Microvascular degeneration in hereditary cystatin C amyloid angiopathy of the brain. APMIS 1997;105:41-7.
11. 11. Jonsdottir S, Palsdottir A. Molecular diagnosis of hereditary cystatin C amyloid angiopathy. Biochem Med Metab Biol 1993;49:117-23.
12. 12. Sveinbjornsdottir S, Blondal H, Gudmunsson G, Kjartansson O, Jonsdottir S, Gudmundsson G. Progressive dementia and leukoencephalopathy as the initial presentation of two cases. J Neurol Sci 1996; 140:101-8.
13. 13. Coria F, Prelli F, Castano EM et al. Beta-protein deposition: a pathogenetic link between Alzheimer's disease and cerebral amyloid angiopathies. Brain Res 1989;480:407.
14. 14. Itoh Y, Yamada M, Hayakawa M, Otomo E, Miyatake T. Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 1993;116:135-41.
15. 15. Shimode K, Fujihara S, Nakamura M, Kobayashi S, Tsunematsu T. Diagnosis of cerebral amyloid angiopathy by enzyme-linked immunosorbent assay of cystatin C in cerebrospinal fluid. Stroke 1991;22:860-6.
16. 16. Shimode K, Kobayashi S, Imaoka K, Umegae N, Nagai A. Leukoencephalopathy-related cerebral amyloid angiopathy with cystatin C deposition. Stroke 1996;27:1417-19.
17. 17. Haan J, Maat-Schieman ML, Roos RA. Clinical aspects of cerebral amyloid angiopathy. Dementia 1994;5:210-13.
18. 18. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, ed. 4, Washington, DC: American Psychiatric Association, 1994.
19. 19. McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
20. 20. World Health Organisation (WHO). The neurological adaptation of the International Classification of Diseases (ICD-10NA). Geneva: World Health Organisation, 1991.
21. 21. Roman GC, Tatemichi TK, Erkinjuntti T et al. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
22. 22. Pullicino P, Benedict RHB, Capruso DX et al. Neuro-imaging criteria for vascular dementia. Arch Neurol 1996; 53:723-8.
23. 23. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992;38: S20-7.
24. 24. Ishiguro H, Ohkubo I, Mizokami M, Titani K, Sasaki M. The use of monoclonal antibodies to define levels of cystatin C in normal human serum. Hybridoma 1989;8:303-13.
25. 25. Tomonaga M. Cerebral amyloid angiopathy in the elderly. J Am Geriatr Soc 1981;29:151-7.
26. 26. Vinters HV. Cerebral amyloid angiopathy: A critical review. Stroke 1987;18:311-24.
27. 27. Allsop D, Landon M, Kidd M, Lowe JS, Reynolds GP, Gardner A. Monoclonal antibodies raised against a subsequence of senile plaque core protein react with plaque cores, plaque periphery and cerebrovascular amyloid in Alzheimer's disease. Neurosci Lett 1998;68:252-6.
28. 28. Fujihara S, Shimode K, Nakamura M, Kobayashi S, Tsunematsu T. Cerebral amyloid angiopathy with the deposition of cystatin C (gamma trace) and B-protein. Progr Clin Biol Res 1989;317:939-44.
29. 29. Vinters HV, Secor DL, Pardridge WM, Gray F. Immunohistochemical study of cerebral amyloid angiopathy. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy. Ann Neurol 1990;28:34-42.